Differential regulation of somatostatin receptor types 1–5 in rat aorta after angioplasty
- 1 February 1999
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 13 (2) , 387-394
- https://doi.org/10.1096/fasebj.13.2.387
Abstract
Treatment of restenosis after angioplasty with octapeptide somatostatin (SST) analogs has met with variable success. These analogs bind with high affinity to only two SST receptor (SSTR) subtypes (2 and 5), display moderate affinity for SSTR3, and low affinity for SSTR1 and 4. To optimize the vasculoprotective effect of SST, we have investigated the pattern of expression of all five SSTRs in rat thoracic aorta in the resting state and at 15 min, 3, 7, and 14 days after balloon endothelial denudation. SSTR1-5 were analyzed as mRNA by semiquantitative reverse transcriptase-polymerase chain reaction and as protein by immunocytochemistry. All five SSTRs were expressed in rat aorta both as mRNA and protein and displayed a time-dependent, subtype-selective response to endothelial denudation. mRNA for SSTR1 and 2 increased acutely (SSTR1 > SSTR2) on days 3 and 7, coincident with smooth muscle cell (SMC) proliferation, and declined to basal levels by day 14. SSTR3 and 4 displayed a different pattern with a delayed, more gradual increase in mRNA beginning at days 3–7 and continued to increase thereafter. SSTR5 mRNA was constitutively expressed at a low level and showed no change during the 2 wk postinjury period. By immunohistochemistry, SSTR1-5 antigens were localized predominantly in SMC that were present in the media or had migrated into the intima; antigen expression correlated with receptor mRNA expression. Notably, only SSTR1,3,4 were expressed in the intima: SSTR1 and 4 during the proliferative burst and SSTR3 and 4 after proliferation, when SMC migration into the intima continues. These results demonstrate dynamic changes in SSTR1-5 expression after vascular trauma localized to areas of vascular SMC migration and replication. In view of their early and prominent induction, SSTR1 may be the optimal subtype to target for inhibition of myointimal proliferation, and SSTR3 and 4 for migration and remodeling.—Khare, S., Kumar, U., Sasi, R., Puebla, L., Calderon, L., Lemstrom, K., Hayry, P., Patel, Y. C. Differential regulation of somatostatin receptor types 1-5 in rat aorta after angioplasty.Keywords
Funding Information
- Tekes
- Academy of Finland
- European Commission
- Helsingin Yliopisto
This publication has 44 references indexed in Scilit:
- Cloning of the gene encoding human somatostatin receptor 2: Sequence analysis of the 5′-flanking promoter regionGene, 1995
- Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplastyAmerican Heart Journal, 1995
- Characterization of the Proximal Promoter Region of the Rat Somatostatin Receptor Gene, SSTR4Biochemical and Biophysical Research Communications, 1995
- Somatostatin Regulates Somatostatin Receptor Subtype mRNA Expression in GH3 CellsBiochemical and Biophysical Research Communications, 1994
- Sequence analysis of the promoter region of the rat somatostatin receptor subtype 1 geneFEBS Letters, 1994
- Chronic Allograft RejectionImmunological Reviews, 1993
- Multiple Gene Transcripts of the Somatostatin Receptor SSTR2: Tissue-Selective Distribution and cAMP RegulationBiochemical and Biophysical Research Communications, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984
- SomatostatinNew England Journal of Medicine, 1983